BDSXBiodesix, Inc.

$138M

FY 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$25M+20.2% YoY

Gross Profit

$18M75.3% margin

Operating Income

-$27M-108.9% margin

Net Income

-$31M-125.1% margin

EPS (Diluted)

$-0.67

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$23M

Stock-Based Comp.

$170,000

Balance Sheet

Total Assets

$42M

Total Liabilities

$270M

Stockholders' Equity

-$229M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$25M	$20M	+20.2%
Gross Profit	$18M	$16M	+15.3%
Operating Income	-$27M	-$23M	-14.0%
Net Income	-$31M	-$26M	-17.4%

BDSX FY 2019 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena